Peripheral loss of CD8(+)CD161(++)TCRV7 center dot 2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patientsShow others and affiliations
2016 (English)In: European Journal of Clinical Investigation, ISSN 0014-2972, E-ISSN 1365-2362, Vol. 46, no 2, p. 170-180Article in journal (Refereed) Published
Resource type
Text
Abstract [en]
BackgroundMucosal-associated invariant T (MAIT) cells play an important role in innate host defence. MAIT cells appear to undergo exhaustion and are functionally weakened in chronic viral infections. However, their role in chronic hepatitis C virus (HCV) infection remains unclear. Materials and methodsWe investigated the frequency of CD8(+)CD161(++)TCR V7.2(+) MAIT cells in a cross-sectional cohort of chronic HCV-infected patients (n = 25) and healthy controls (n = 25). Peripheral blood mononuclear cells were investigated for circulating MAIT cell frequency, liver-homing (CCR5 and CD103), biomarkers of immune exhaustion (PD-1, TIM-3 and CTLA-4), chronic immune activation (CD38 and HLA-DR), and immunosenescence (CD57) by flow cytometry. ResultsThe frequency of MAIT cells was significantly decreased, and increased signs of immune exhaustion and chronic immune activation were clearly evident on MAIT cells of HCV-infected patients. Decrease of CCR5 on circulating MAIT cells is suggestive of their peripheral loss in chronic HCV-infected patients. MAIT cells also showed significantly increased levels of HLA-DR, CD38, PD-1, TIM-3 and CTLA-4, besides CD57 in chronic HCV disease. ConclusionsImmune exhaustion and senescence of CD8(+)CD161(++)TCR V7.2(+) MAIT cells could contribute to diminished innate defence attributes likely facilitating viral persistence and HCV disease progression.
Place, publisher, year, edition, pages
WILEY-BLACKWELL , 2016. Vol. 46, no 2, p. 170-180
Keywords [en]
CD38; exhaustion; HCV infection; MAIT cells; PD-1; TCRV alpha 7.2
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-125301DOI: 10.1111/eci.12581ISI: 000368689100007PubMedID: 26681320OAI: oai:DiVA.org:liu-125301DiVA, id: diva2:906380
Note
Funding Agencies|High Impact Research (HIR), University of Malaya [UM.C.625/1/HIR/139]; University Malaya Fellowship Scheme [AI52731]; Swedish Research Council; Swedish Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University Hospital Research Fund; CALF; Swedish Society of Medicine
2016-02-242016-02-192017-11-30